| Poster
Session I |
13:00-14:30 k90l | ||
| Chairs: Yasuo Ariumi & Yorifumi Satou | |||
| 13:00-13:40 y40z | One-minute presentation | ||
| 13:40-14:30 y50z | Discussion for posters with one-minute presentation | ||
| Session
VII |
14:30-16:00 k90l | ||
| Chairs: Shogo Misumi & Hiroyuki Gatanaga | |||
 |
O-2-12 |
Shinya
Suzu Kumamoto University, Japan |
In vitro and in vivo susceptibility of circulating fibrocytes to HIV-1 |
 |
O-2-13 |
Hirokazu
Tamamura Tokyo Medical and Dental University, Japan |
An anti-HIV assay method for cell-penetrating peptides using chloroquine and identification of inhibitory peptides derived from matrix proteins |
 |
O-2-14 |
Kenji
Maeda NCGM, Japan |
Development of novel nucleoside reverse transcriptase inhibitors potent against HIV and HBV |
| Session
VIII |
16:00-17:00 k60l | ||
| Chairs: Yosuke Maeda & Yasuo Ariumi | |||
 |
O-2-15 |
Kazuhisa
Yoshimura NIID / Kumamoto University, Japan |
Development of novel bifunctional entry inhibitors; from NBD-556 to next generations |
 |
O-2-16 |
Tetsuro
Matano NIID / Kumamoto University, Japan |
Antigen-specific CD8+ T-cell responses in rhesus macaque lymph nodes in the chronic phase of SIVmac239 infection |
| Session
IX |
17:00-17:45 k45l | ||
| Chair: Shuzo Matsushita | |||
 |
O-2-17 |
Jerome
Kim IVI, Korea |
Vaccine Development Against HIV-1 |
 |
Extra Talk |
Robert
Murphy Northwestern University, USA |
Progress in HIV
Therapy 2015 VAC 3S: Immune Protection |
| 19:00-21:00
k120l |
Reception | ||